Tag: Generics

A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.

Indivior Launches Generic of SUBOXONE®

Indivior PLC announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S. The authorized ge...

Dr. Reddy’s Launched Generic of Adcirca

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s” announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tad...

USP Announced Generics Access Plan

USP announced its Generics Access Plan, helping to increase access to medicines by facilitating generics competition through new and revised quality standards and related activities, including collabo...

Teva Announced Launch of Generic for CPS

Teva Pharmaceutical Industries Ltd., today announced the launch of a generic version of Sabril®¹ (vigabatrin) tablets, 500 mg in the US. Vigabatrin oral tablets are indicated as adjunctive therapy ...

FDA Approved Mylan’s Asthma Generic

The U.S. Food and Drug Administration (FDA) approved Mylan NV’s generic version of GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher on Wednesday....

First Generic Version of Sabril Approved by FDA

Approval of generic vigabatrin tablets granted to Teva Pharmaceuticals USA. The FDA has approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex partial seizure...

Brexit Affects Supply and Prices in UK Pharmacies

The BBC’s 5 Live Breakfast reported that pharmacies are stockpiling generic drugs, and prices are fluctuating amid the political uncertainty. Manufacturers of branded drugs have been stockpiling th...

Japanese pharma industry energized by the next wave of growth

Japan’s pharmaceutical industry is the third largest worldwide after the US and China with a share of approximately ten percent of the world market and a value expected to reach $109 billion by 2026.

Aurobindo Pharma strengthens its European business

Aurobindo Pharma announced the signing of a definitive agreement to acquire from Apotex International, its commercial operations and certain supporting infrastructure in five European countries.

Sanofi and Advent completed negotiations for the acquisition of Zentiva

Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi's European generics business, by Advent and the companies have signed a Share Purchase Agreement worth €1.9 billion

Russia is ready to supply insulin to Bulgaria

Parallel export of drugs which, for some medicines, reached more than 20%, has created serious problems for diabetics. Russia is ready to fill the shortage and start exporting insulin to Bulgaria.

Russia is expected to simplify the registration of a dosage form

The state registration of generic drugs in the form of concentrates for solutions will no longer require a report on bioequivalence studies. A relevant draft law was adopted by the Russian State Duma in the first reading.

Swiss pharma companies are suspected of hampering generics development

The United States Food and Drug Administration published a list of pharmaceutical companies, all of which are suspected of hindering the development of generic versions of their own medicines.

Glenmark Pharma launched its asthma drug generic in Denmark

Glenmark Pharmaceuticals Europe has launched a generic version of Seretide Accuhaler, used to treat asthma, in Denmark. The product was developed by Celon Pharma.

Lannett bought portfolio of generic products from Endo International

Lannett Company announced that it has acquired 23 approved and one pending drug product applications from a subsidiary of Endo International for an upfront payment plus future milestone payments. T...

Alvogen received European approval for generic Lenalidomide

Alvogen announced that it has successfully concluded multiple registration procedures for Lenalidomide capsules. Alvogen received regulatory clearance for its product in several European countries.